Edition:
India

Sierra Oncology Inc (SRRA.OQ)

SRRA.OQ on NASDAQ Stock Exchange Global Market

1.45USD
22 Apr 2019
Change (% chg)

-- (--)
Prev Close
$1.45
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
49,603
52-wk High
$3.70
52-wk Low
$1.07

About

Sierra Oncology, Inc., formerly ProNAi Therapeutics, Inc., is a clinical-stage drug development company. The Company’s lead drug candidate, SRA737, is orally bioavailable small molecule inhibitor of Checkpoint kinase 1 (Chk1), a key cell cycle checkpoint and central regulator of the deoxyribonucleic acid (DNA) Damage Response... (more)

Overall

Beta: 1.72
Market Cap(Mil.): $107.98
Shares Outstanding(Mil.): 74.47
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates